| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/03/2009 | US20090220981 Compositions and methods for determining the presence of chlamydophila pneumoniae in a test sample |
| 09/03/2009 | US20090220980 Use of methylation status of mint loci and tumor-related genes as a marker for melanoma and breast cancer |
| 09/03/2009 | US20090220979 Methods and Apparatus for Magnetic Separation of Cells |
| 09/03/2009 | US20090220978 Methods for detection and quantification of analytes in complex mixtures |
| 09/03/2009 | US20090220977 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 09/03/2009 | US20090220976 Test Method for MALT Lymphomas and Kit Therefor |
| 09/03/2009 | US20090220975 Use of protein satb2 as a marker for colorectal cancer |
| 09/03/2009 | US20090220974 Methods and apparatus for the selection and/or processing of particles, in particular for the selective and/or optimised lysis of cells |
| 09/03/2009 | US20090220973 Obesity and body fat distribution |
| 09/03/2009 | US20090220972 Probe, Probe Set, Probe-Immobilized Carrier, and Genetic Testing Method |
| 09/03/2009 | US20090220971 Treatment Response in Generalized Social Phobia |
| 09/03/2009 | US20090220970 Drug screening and toxicity assays comparing gene expression in relation to test compound to gene expression in relation to known hepatotoxins such as acetaminophen |
| 09/03/2009 | US20090220969 Identifying and quantifying small RNAs |
| 09/03/2009 | US20090220968 Methods and Apparatus for Near Field Irradiation |
| 09/03/2009 | US20090220967 Systemic Carnitine Deficiency Gene and Uses Thereof |
| 09/03/2009 | US20090220966 Thermocycler and sample port |
| 09/03/2009 | US20090220965 Methods for prognosing the recurrence of gastrointestinal and other cancers using the shc proteins |
| 09/03/2009 | US20090220964 Methods for diagnosing and treating cancers via manipulations of a...pathway |
| 09/03/2009 | US20090220963 Kit suitable for screening and establisment of optimal amplification condition in pcr constructed with dried-formulated pcr reagent and method for producing the same |
| 09/03/2009 | US20090220962 Nucleotide sequences coding cyanopeptide metabolites for potential use as angiotensin converting enzyme inhibitors and in treatment of aterial stenosis and high blood pressure |
| 09/03/2009 | US20090220961 Fluorescent Primer System For Detection Of Nucleic Acids (Q Priming) |
| 09/03/2009 | US20090220960 Luciferase gene optimized for use in imaging of intracellular luminescence |
| 09/03/2009 | US20090220959 Markers of definitive endoderm |
| 09/03/2009 | US20090220958 Method for diagnosing hepatic diseases and screening method of molecules for treatment of hepatic disease |
| 09/03/2009 | US20090220957 Membrane assay method |
| 09/03/2009 | US20090220956 Prediction of Local Recurrence of Breast Cancer |
| 09/03/2009 | US20090220955 Methods and composition to generate unique sequence dna probes labeling of dna probes and the use of these probes |
| 09/03/2009 | US20090220954 Methods of diagnosing cardiovascular disease |
| 09/03/2009 | US20090220953 Identification of ancestral haplotypes and uses thereof |
| 09/03/2009 | US20090220952 Compositions And Methods For Analyzing Protein Interactions |
| 09/03/2009 | US20090220951 Methods and compositions for classifying bacillus bacteria |
| 09/03/2009 | US20090220950 Simultaneous quantification of nucleic acids in diseased cells |
| 09/03/2009 | US20090220949 Mutations Associated with the Long QT Syndrome and Diagnostic Use Thereof |
| 09/03/2009 | US20090220948 Methods and Device for Transmitting, Enclosing and Analysing Fluid Samples |
| 09/03/2009 | US20090220947 Biomarkers for toxic algae |
| 09/03/2009 | US20090220946 Adenovirus status as a predictor of body composition change, disease status, and treatment outcomes |
| 09/03/2009 | US20090220945 HPV E6, E7 mRNA ASSAY AND METHODS OF USE THEREOF |
| 09/03/2009 | US20090220944 Method to measure and characterize microvesicles in the human body fluids |
| 09/03/2009 | US20090220943 Hcv genotyping and phenotyping |
| 09/03/2009 | US20090220942 Activated split-polypeptides and methods for their production and use |
| 09/03/2009 | US20090220941 Compositions for- detecting of influenza viruses and kits and methods using same |
| 09/03/2009 | US20090220940 Method for Testing the Integrity of Membranes |
| 09/03/2009 | US20090220939 Methods for determing resistance or susceptibility to hi entry inhibitors |
| 09/03/2009 | US20090220938 Viral nucleoprotein detection using an ion channel switch biosensor |
| 09/03/2009 | US20090220937 Compositions for Use in Identification of Adventitious Viruses |
| 09/03/2009 | US20090220936 Flow Cytometry Reagent System |
| 09/03/2009 | US20090220931 Functional in vitro immunoassay |
| 09/03/2009 | US20090220589 Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas |
| 09/03/2009 | US20090220549 Reagents for recombinogenic engineering and use thereof |
| 09/03/2009 | US20090220540 Helicobacter System and Uses Thereof |
| 09/03/2009 | US20090220526 Acute renal injury |
| 09/03/2009 | US20090220525 Novel Bacterium and Vaccine |
| 09/03/2009 | US20090220515 Treatment and prevention of renal disease |
| 09/03/2009 | US20090220512 Genes and polypeptides relating to prostate cancers |
| 09/03/2009 | US20090220511 human polypeptides named IFN (interferon)- lambda 1, IFN- lambda 2 and IFN- lambda 3 and IFN- lambda R1; antiviral agents |
| 09/03/2009 | US20090220507 Inhibition of extracellular signal-regulated kinase 1/2 as a treatment for cardiac hypertrophy and heart failure |
| 09/03/2009 | US20090220498 Method for Discovering Inhibitors of the Epstein-Barr Virus-Induced Gene 3 (EBI3) and Derivatives Thereof for the Treatment of Metastasizing Tumors and Allergic Asthma |
| 09/03/2009 | US20090220495 Cancer Related Genes (PRLR) |
| 09/03/2009 | US20090220491 Binding agents which inhibit myostatin |
| 09/03/2009 | US20090220488 Evaluating and treating scleroderma |
| 09/03/2009 | US20090220487 via blocking proteins and signal transduction pathways, with peptide which inhibits p21-activated kinase (PAK)-PIX-GIT interaction or complex formation; mitogen-activated protein kinase inhibitors; tissue damage, ischemia, inflammation, stroke, wound healing, acute respiratory distress syndrome |
| 09/03/2009 | US20090220479 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart disease |
| 09/03/2009 | US20090220476 Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof |
| 09/03/2009 | US20090220469 Peptides against autoantibodies associated with glaucoma and use of these peptides |
| 09/03/2009 | US20090220462 Stem cells |
| 09/03/2009 | US20090220460 Virus strains |
| 09/03/2009 | US20090220453 Enhancing stem cell mobilization |
| 09/03/2009 | US20090220432 Imaging agents and methods of using same for detecting multidrug resistance in cancer |
| 09/03/2009 | US20090220416 Immunoglobulin associated cell-surface determinants in the treatment of b-cell disorders |
| 09/03/2009 | US20090218547 Methods, compositions, and kits for protein crystallization |
| 09/03/2009 | DE102008011850A1 Biomarker für die Diagnose von Hirntumor Biomarkers for the diagnosis of brain tumor |
| 09/03/2009 | CA2717067A1 Method for evaluating oil-and-fat amount in seed and method for screening for plant exhibiting varied level of oil-and-fat content |
| 09/03/2009 | CA2717030A1 Microrna signatures associated with cytogenetics and prognosis in acute myeloid leukemia (aml) and uses thereof |
| 09/03/2009 | CA2717026A1 Microrna signatures associated with human chronic lymphocytic leukemia (ccl) and uses thereof |
| 09/03/2009 | CA2716938A1 Microrna-based methods and compositions for the diagnosis, pronosis and treatment of prostate related disorders |
| 09/03/2009 | CA2716906A1 Microrna-based methods and compositions for the diagnosis, prognosis and treatment of gastric cancer |
| 09/03/2009 | CA2716852A1 High-molecular-weight adiponectin measurement method |
| 09/03/2009 | CA2716849A1 Methods and kits for detecting congenital stationary night blindness and selecting different coat patterns |
| 09/03/2009 | CA2716766A1 Expression vector for mass production of foreign gene-derived protein using animal cell and use thereof |
| 09/03/2009 | CA2716643A1 Microrna (mirna) and downstream targets for diagnostic and therapeutic purposes |
| 09/03/2009 | CA2716623A1 Use of sip1 as determinant of breast cancer stemness |
| 09/03/2009 | CA2716545A1 Combination of marker genes for characterizing a lactobacillus sakei strain |
| 09/03/2009 | CA2716498A1 Serotonin transporter gene and treatment of alcoholism |
| 09/03/2009 | CA2716081A1 System and method for improved processing of nucleic acids for production of sequencable libraries |
| 09/03/2009 | CA2711572A1 Methods and compositions for increased yield |
| 09/03/2009 | CA2708038A1 Slope-based compensation |
| 09/03/2009 | CA2698569A1 Tumor grading and cancer prognosis |
| 09/02/2009 | EP2096440A1 Method for stabilizing -thrombin in thrombin-containing solution |
| 09/02/2009 | EP2096437A1 Biosensor, measuring instrument for biosensor, and method of quantifying substrate |
| 09/02/2009 | EP2096436A1 Biosensor, measuring instrument for biosensor, and method of quantifying substrate |
| 09/02/2009 | EP2096435A1 Biosensor, measuring instrument for biosensor, and method of quantifying substrate |
| 09/02/2009 | EP2096432A1 Method for measuring 1,5-anhydroglucitol in whole blood, and sensor chip and measurement kit to be used in the method |
| 09/02/2009 | EP2096180A1 Combination of marker genes for characterizing a Lactobacillus sakei strain |
| 09/02/2009 | EP2096179A1 Separation/purification method and microfluid circuit |
| 09/02/2009 | EP2096178A1 Detection of lymph node metastasis from gastric carcinoma |
| 09/02/2009 | EP2096173A1 Method of measuring glycolated hemoglobin A1C, enzyme to be used therefor and process for producing the same |
| 09/02/2009 | EP2096171A1 MicroRNA (miRNA) and down-stream targets for diagnostic and therapeutic purposes |
| 09/02/2009 | EP2096163A1 Rotary extraction container, method of identifying cell species and method of detecting gene using the same, and automatic nucleic acid extractor |
| 09/02/2009 | EP2096110A1 Acridane-9-dithiocarboxylate derivatives for generating chemiluminescence with a peroxidase |
| 09/02/2009 | EP2095127A1 Methods for screening and treatment involving the genes gypc, agpat3, agl, pvrl2, hmgb 3, hsdl2 and/or ldb2 |